VA Augusta’s Innovative Devices Improve Life Quality for Deaf Veterans
Marine Corps Veteran, James Rush, can now communicate with ease thanks to XanderGlasses. The device, provided by VA Augusta Health Care System, displays real-time closed captions, revolutionizing the way Rush and others with hearing loss engage in conversations.
From the Politics Desk: Trump Downplays Recession Fears, Australia Elections
Get the latest political analysis from NBC News Politics. Today's edition includes an interview with President…
Eli Lilly to Participate in Bank of America Securities 2025 Healthcare Conference
Eli Lilly and Company to participate in the Bank of America Securities 2025 Healthcare Conference, live webcast…
US clean energy growth hindered by policy, tax uncertainty
Uncertainty over clean energy tax credits and Trump's tariffs is hindering U.S. clean energy development, say experts at DC Climate Week.
Illinois Man Gets 30 Years for Hate Crime Murder of Palestinian Boy
TL/DR -
An Illinois man has been sentenced to a lengthy prison term for the hate crime killing of a 6-year-old…
Trump Family’s Crypto Firm Announces $2B Deal with Abu Dhabi-Backed Fund
Abu Dhabi-backed fund to make a $2 billion business deal using Trump family cryptocurrency, highlighting ethical…
Revolutionary Robotic Hip Replacement Enhances Fitness in Fort Lauderdale
Keeping Active with Gwynne Beatty
For fitness and dance lover Gwynne Beatty, an active lifestyle was a key part of her daily routine until arthritis made simple movements a struggle. This led her to seek medical help for her condition.
Challenging the Pain
Despite trying various arthritis treatments including…
Sen. Blackburn fights for online child protection & Trump’s bill
Explore the key priorities for the next 100 days of President Trump's term including the passing of "one big,…
Arizona Governor’s 2026 Survival Threatened by MAGA Aims
Democratic Gov. Katie Hobbs faces a tough reelection campaign, which could be made easier if Republicans nominate…
Disparities in Access to Obesity Drug GLP-1 Agonists in the US Unveiled
Under 3% of eligible US obesity patients receive prescriptions for GLP-1 receptor agonists, with disparities by sex, race, and location.